BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22465427)

  • 1. Association between recurrent metastasis from stage II and III primary colorectal tumors and moderate microsatellite instability.
    Garcia M; Choi C; Kim HR; Daoud Y; Toiyama Y; Takahashi M; Goel A; Boland CR; Koi M
    Gastroenterology; 2012 Jul; 143(1):48-50.e1. PubMed ID: 22465427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MSI-L/EMAST is a predictive biomarker for metastasis in colorectal cancer patients.
    Torshizi Esfahani A; Seyedna SY; Nazemalhosseini Mojarad E; Majd A; Asadzadeh Aghdaei H
    J Cell Physiol; 2019 Aug; 234(8):13128-13136. PubMed ID: 30549036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
    Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
    Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
    Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
    Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is elevated microsatellite alterations at selected tetranucleotide repeats (EMAST)-negative/MSI-high colorectal cancer a distinct subtype of the disease?
    Park Y; Kim DW; Hong YJ; Park KU; Nam SK; Na HY; Lee HS; Kim MH; Oh HK; Kang SB
    J Surg Oncol; 2020 Dec; 122(7):1462-1469. PubMed ID: 32779222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features.
    Lee HS; Park KU; Kim DW; Lhn MH; Kim WH; Seo AN; Chang HE; Nam SK; Lee SY; Oh HK; Kang SB
    Curr Mol Med; 2016; 16(9):829-839. PubMed ID: 27889996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated microsatellite alterations at selected tetranucleotides in early-stage colorectal cancers with and without high-frequency microsatellite instability: same, same but different?
    Watson MM; Lea D; Rewcastle E; Hagland HR; Søreide K
    Cancer Med; 2016 Jul; 5(7):1580-7. PubMed ID: 27061136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMAST Type of Microsatellite Instability-A Distinct Entity or Blurred Overlap between Stable and MSI Tumors.
    Vuković Đerfi K; Salar A; Cacev T; Kapitanović S
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) in Colorectal Cancer is Associated with an Elderly, Frail Phenotype and Improved Recurrence-Free Survival.
    Watson MM; Kanani A; Lea D; Khajavi RB; Søreide JA; Kørner H; Hagland HR; Søreide K
    Ann Surg Oncol; 2020 Apr; 27(4):1058-1067. PubMed ID: 31686344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite instability at tetranucleotide repeats in sporadic colorectal cancer in Japan.
    Yamada K; Kanazawa S; Koike J; Sugiyama H; Xu C; Funahashi K; Boland CR; Koi M; Hemmi H
    Oncol Rep; 2010 Feb; 23(2):551-61. PubMed ID: 20043121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering Elevated Microsatellite Alterations at Selected Tetra/Pentanucleotide Repeats, Microsatellite Instability, and Loss of Heterozygosity in Colorectal Cancers.
    Wang Y; Vnencak-Jones CL; Cates JM; Shi C
    J Mol Diagn; 2018 May; 20(3):366-372. PubMed ID: 29474982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMAST status as a beneficial predictor of fluorouracil-based adjuvant chemotherapy for Stage II/III colorectal cancer.
    Mohammadpour S; Goodarzi HR; Jafarinia M; Porhoseingholi MA; Nazemalhosseini-Mojarad E
    J Cell Physiol; 2020 Apr; 235(4):3604-3611. PubMed ID: 31549400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite instability, EMAST, and morphology associations with T cell infiltration in colorectal neoplasia.
    Lee SY; Miyai K; Han HS; Hwang DY; Seong MK; Chung H; Jung BH; Devaraj B; McGuire KL; Carethers JM
    Dig Dis Sci; 2012 Jan; 57(1):72-8. PubMed ID: 21773681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMAST is associated with a poor prognosis in microsatellite instable metastatic colorectal cancer.
    Venderbosch S; van Lent-van Vliet S; de Haan AF; Ligtenberg MJ; Goossens M; Punt CJ; Koopman M; Nagtegaal ID
    PLoS One; 2015; 10(4):e0124538. PubMed ID: 25884216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.
    Kim CG; Ahn JB; Jung M; Beom SH; Kim C; Kim JH; Heo SJ; Park HS; Kim JH; Kim NK; Min BS; Kim H; Koom WS; Shin SJ
    Br J Cancer; 2016 Jun; 115(1):25-33. PubMed ID: 27228287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of carcinoembryonic antigen is influenced by microsatellite instability genotype and stage in locally advanced colorectal cancers.
    Søreide K; Søreide JA; Kørner H
    World J Surg; 2011 Apr; 35(4):888-94. PubMed ID: 21301835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence of EMAST in whole genome sequencing data from 248 colorectal cancers.
    Kondelin J; Martin S; Katainen R; Renkonen-Sinisalo L; Lepistö A; Koskensalo S; Böhm J; Mecklin JP; Cajuso T; Hänninen UA; Välimäki N; Ravantti J; Rajamäki K; Palin K; Aaltonen LA
    Genes Chromosomes Cancer; 2021 Jul; 60(7):463-473. PubMed ID: 33527622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer.
    Watson MM; Lea D; Gudlaugsson E; Skaland I; Hagland HR; Søreide K
    Cancer Immunol Immunother; 2020 Aug; 69(8):1627-1637. PubMed ID: 32314040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite alterations at selected tetranucleotide repeats are associated with morphologies of colorectal neoplasias.
    Lee SY; Chung H; Devaraj B; Iwaizumi M; Han HS; Hwang DY; Seong MK; Jung BH; Carethers JM
    Gastroenterology; 2010 Nov; 139(5):1519-25. PubMed ID: 20708618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between MSH3 immunohistochemistry and microsatellite analysis for the detection of elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) in colorectal cancers.
    Laycock A; Kang A; Ang S; Texler M; Bentel J
    Hum Pathol; 2021 Dec; 118():9-17. PubMed ID: 34537247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.